Raquel Hontecillas
Fondateur chez Nutritional Immunology & Molecular Medicine Laboratory
Profil
Raquel Hontecillas is the founder and the Chief Scientific Officer & Co-Director of the Nutritional Immunology & Molecular Medicine Laboratory, founded in 2002.
She is also the Chief Scientific Officer of Biotherapeutics, Inc. since 2008.
Dr. Hontecillas's former positions include being a Professor at Virginia Polytechnic Institute & State University from 2008 to 2020, and the Chief Scientific Officer of Landos Biopharma, Inc. from 2017 to 2022.
Dr. Hontecillas's education includes a doctorate from Iowa State University and an undergraduate degree from Universidad Complutense de Madrid.
Postes actifs de Raquel Hontecillas
| Sociétés | Poste | Début |
|---|---|---|
Biotherapeutics, Inc.
 Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Directeur Technique/Scientifique/R&D | 01/10/2008 |
| Nutritional Immunology & Molecular Medicine Laboratory | Fondateur | 01/07/2002 |
Anciens postes connus de Raquel Hontecillas
| Sociétés | Poste | Fin |
|---|---|---|
| LANDOS BIOPHARMA, INC. | Directeur Technique/Scientifique/R&D | 05/04/2022 |
| Virginia Polytechnic Institute & State University | Corporate Officer/Principal | 01/07/2020 |
Formation de Raquel Hontecillas
| Iowa State University | Doctorate Degree |
| Universidad Complutense de Madrid | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LANDOS BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Biotherapeutics, Inc.
Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Health Technology |
| Nutritional Immunology & Molecular Medicine Laboratory |
